BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.630
-0.040 (-1.50%)
At close: Mar 16, 2026, 4:00 PM EDT
2.602
-0.028 (-1.07%)
After-hours: Mar 16, 2026, 6:28 PM EDT
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
$454,821
Profits / Employee
-$106,321
Market Cap
11.21M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 28 | -51 | -64.56% |
| Dec 31, 2023 | 79 | 30 | 61.22% |
| Dec 31, 2022 | 49 | 11 | 28.95% |
| Dec 31, 2021 | 38 | 0 | - |
| Dec 31, 2020 | 38 | -4 | -9.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Curis | 34 |
| Soligenix | 16 |
| CalciMedica | 16 |
| NewcelX | 15 |
| BioVie | 13 |
| Purple Biotech | 9 |
| Quoin Pharmaceuticals | 5 |
BLRX News
- 4 months ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 4 months ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 4 months ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 4 months ago - BioLine Rx's Earnings: A Preview - Benzinga
- 4 months ago - BioLineRx to Report Third Quarter 2025 Results on November 24, 2025 - PRNewsWire
- 4 months ago - BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types - PRNewsWire